Monocyte-to-lymphocyte ratio as a prognostic factor in peripheral whole blood samples of colorectal cancer patients

Figure 1 Three- and five-year disease-free survival rates according to monocyte count and monocyte to lymphocyte ratio in colorectal cancer patients, before and after surgery, respectively. Kaplan-Meier curves were used to identify factors for colorectal cancer survival. A and B: Monocyte count before surgery [3- and 5-yr disease-free survival (DFS)]; C and D: Monocyte count after surgery (3- and 5-yr DFS); E and F: Monocyte to lymphocyte ratio before surgery (3- and 5-yr DFS); G and H: Monocyte to lymphocyte ratio after surgery (3- and 5-yr DFS).

Figure 2 Three- and five-year disease-free survival rates according to neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio status and platelet and neutrophil-to-lymphocyte ratio status in colorectal cancer patients, before and after surgery, respectively. Kaplan-Meier curves were used to identify factors for colorectal cancer survival. A and B: Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio status before surgery [3- and 5-yr disease-free survival (DFS)]; C and D: Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio status after surgery (3- and 5-yr DFS); E and F: Platelet and neutrophil-to-lymphocyte ratio status before surgery (3- and 5-yr DFS); G and H: Platelet and neutrophil-to-lymphocyte ratio status after surgery (3- and 5-year DFS).